Get the Stockscreener App
5.68
1.07%
0.06
After Hours:
5.68
Alpha Teknova Inc Stock (TKNO) Latest News
Teknova And Pluristyx Launch PluriFreeze Cryopreservation System To Streamline Cell Therapy - Nasdaq
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - The Manila Times
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
How the (TKNO) price action is used to our Advantage - Stock Traders Daily
Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Increase in Short Interest - Defense World
Sector Update: Health Care Stocks Decline Wednesday Afternoon - TradingView
Sector Update: Health Care -March 12, 2025 at 08:46 am EDT - Marketscreener.com
Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies -March 12, 2025 at 04:23 am EDT - Marketscreener.com
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - The Manila Times
Alpha Teknova and Pluristyx Announce Collaboration to Commercialize PluriFreeze Cryopreservation System for Cell Therapies - Nasdaq
Teknova, Pluristyx announce collaboration over next-generation cell therapies - TipRanks
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67 - Yahoo Finance
Alpha Teknova, Inc. SEC 10-K Report - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St
Alpha Teknova’s Earnings Call: Growth Amid Challenges - TipRanks
Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call Transcript - MSN
Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential - TipRanks
Alpha Teknova stock holds as KeyBanc maintains rating By Investing.com - Investing.com South Africa
Alpha Teknova stock holds as KeyBanc maintains rating - Investing.com India
Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating - TipRanks
Alpha Teknova: Q4 Earnings Snapshot - Midland Daily News
Alpha Teknova Reports Steady Revenue Growth in 2024 - TipRanks
Earnings call transcript: Alpha Teknova Q4 2024 shows revenue growth, stock edges up - Investing.com India
Alpha Teknova: Q4 Earnings Snapshot -March 04, 2025 at 05:12 pm EST - Marketscreener.com
Alpha Teknova, Inc. Q4 Loss Narrows - Nasdaq
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Alpha Teknova, Inc. Reports 3% Revenue Growth for 2024 and Provides 2025 Guidance of $39-42 Million - Nasdaq
Can Teknova's 110% Clinical Solutions Growth Offset Continued Losses? - StockTitan
Stock Index Futures Mixed as Investors Weigh Trump Tariffs - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February - Defense World
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO) - Simply Wall St
When the Price of (TKNO) Talks, People Listen - Stock Traders Daily
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Manila Times
Alpha Teknova, Inc. Scheduled to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Nasdaq
Q4 Earnings: Can Teknova's Critical Reagents Business Show Growth Momentum? - StockTitan
Nkcfo LLC Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO) - MarketBeat
Leading Driver In The Ready-To-Use Luria-Bertani LB Liquid Medium Market 2025: Surge In R&D Activities Driving - EIN News
Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World
Alpha Teknova (NASDAQ:TKNO) Shares Gap UpTime to Buy? - MarketBeat
Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat
(TKNO) Technical Data - Stock Traders Daily
Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance
Craig-Hallum initiates Alpha Teknova stock with buy rating - MSN
HC Wainwright maintains $18 target on Enanta shares, affirms Buy - MSN
0.19%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):